Physician

Yogeshkumar T. Patel, M.D.

According to 2025 Medicare claims, Yogeshkumar Patel, M.D. (NPI: 1437128527) practices gastroenterology in the Abilene, TX market, with the plurality of this provider's patient population coming from Taylor, TX. This provider's primary affiliated billing organization is TEXAS MIDWEST GASTROENTEROLOGY CENTER, PA (NPI: 1912194317; TIN: 320064427) and primary practice location at 79606-5260. Patel is affiliated with the Caravan Health ACO 43 LLC (ACO ID: A4974) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 944 traditional Medicare patients, billed 17,154 HCPCS/CPT codes, and received $692,478 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,546 prescription claims across 918 beneficiaries totaling $1,047,760 in drug costs, led by Linzess (Linaclotide). Open Payments data shows 94 records totaling $48,970. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $348,628 to $692,478. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,499,415 and ending at $1,047,760. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,302	3,648	$348,628
2016	1,429	4,121	$467,787
2017	1,375	4,139	$538,609
2018	1,073	3,317	$478,977
2019	1,037	4,057	$502,748
2020	1,020	13,023	$653,920
2021	984	14,332	$534,501
2022	955	17,702	$690,028
2023	945	17,045	$688,751
2024	944	17,154	$692,478

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	745	3,277	$1,499,415
2016	694	3,034	$825,290
2017	750	3,336	$1,044,424
2018	791	3,419	$1,032,624
2019	795	3,592	$972,127
2020	753	3,193	$982,672
2021	658	3,023	$1,006,367
2022	806	3,504	$1,194,233
2023	817	3,845	$845,619
2024	918	4,546	$1,047,760

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	714	1,655	$88
88312	Special stained specimen slides to identify organisms including interpretation and report	328	1,079	$63
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	370	399	$61
88313	Special stained specimen slides to examine tissue including interpretation and report	327	1,076	$52
88305	Pathology examination of tissue using a microscope, intermediate complexity	402	2,896	$26

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Linzess	Linaclotide	181	9,195	$159,013
Xifaxan	Rifaximin	40	1,181	$132,343
Rinvoq	Upadacitinib	11	318	$102,101
Zenpep	Lipase/Protease/Amylase	15	517	$62,136
Creon	Lipase/Protease/Amylase	38	1,166	$49,717

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	80	$1,629	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	14	$47,342	PFIZER INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Yogeshkumar T. Patel, M.D.?

Tedicare shows public-source Medicare data for Yogeshkumar T. Patel, M.D. (NPI 1437128527), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Yogeshkumar T. Patel, M.D. have ACO affiliation data?

Yogeshkumar T. Patel, M.D. is shown with ACO affiliation data for Caravan Health ACO 43 LLC (MSSP, ACO ID A4974) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Yogeshkumar T. Patel, M.D.?

Yogeshkumar T. Patel, M.D. is linked to TEXAS MIDWEST GASTROENTEROLOGY CENTER, PA (billing NPI 1912194317) in the available physician profile data.

Does Yogeshkumar T. Patel, M.D. have Open Payments data?

Yogeshkumar T. Patel, M.D. has 94 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.